Tytuł pozycji:
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer.
-
Tytuł:
-
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer.
-
Autorzy:
-
Capri, G.
Chang, J.
Chen, S.-C.
Conte, P.
Cwiertka, K.
Jerusalem, G.
Jiang, Z.
Johnston, S.
Kaufman, B.
Link, J.
Ro, J.
Schütte, J.
Oliva, C.
Parikh, R.
Preston, A.
Rosenlund, J.
Selzer, M.
Zembryki, D.
De Placido, S.
-
Źródło:
-
Annals of Oncology. Mar2010, Vol. 21 Issue 3, p474-480. 7p. 2 Charts, 2 Graphs, 1 Map.
-